This topic contains a solution. Click here to go to the answer

Author Question: A patient is taking acetylsalicylic acid (aspirin) to prevent platelet aggregation. Which dose of ... (Read 57 times)

burchfield96

  • Hero Member
  • *****
  • Posts: 610
A patient is taking acetylsalicylic acid (aspirin) to prevent platelet aggregation. Which dose of aspirin will irreversibly acetylate circulating platelets within a few minutes, with effects lasting for the lifespan of the platelets?
 
  A) 81 mg
  B) 180 mg
  C) 325 mg
  D) 650 mg

Question 2

When acetylsalicylic acid (aspirin) is administered, what action prevents the synthesis of thromboxane A2?
 
  A) Aspirin is a COX-2 inhibitor only and does not affect platelet aggregation.
  B) Aspirin increases vasodilation and thus decreases platelet aggregation.
  C) Aspirin adjusts the pH of the blood to diminish platelet aggregation.
  D) Aspirin's acetyl portion dissociates, binding to COX-1 to decrease aggregation.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Liamb2179

  • Sr. Member
  • ****
  • Posts: 365
Answer to Question 1

C

Answer to Question 2

D




burchfield96

  • Member
  • Posts: 610
Reply 2 on: Jul 23, 2018
:D TYSM


Alyson.hiatt@yahoo.com

  • Member
  • Posts: 354
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The average human gut is home to perhaps 500 to 1,000 different species of bacteria.

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

For a complete list of videos, visit our video library